ADCT
ADC Therapeutics SA
1.10$
+4.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2.5% | 745.4% | 13.9% | 7.0% | 4.6% | 8.1% | 8.9% | 4.4% | 7.3% | 7.4% | 18.0% | 12.2% | 11.3% | |
| 97.5% | -645.4% | 86.1% | 93.0% | 95.4% | 91.9% | 91.1% | 95.6% | 92.7% | 92.6% | 82.0% | 87.8% | 88.7% | |
| 196.2% | 180.6% | 142.6% | 139.5% | 176.0% | 160.3% | 125.6% | 159.7% | 163.2% | 78.9% | 99.2% | 90.2% | 104.4% | |
| 103.9% | 67.3% | 97.5% | 92.4% | 84.6% | 89.6% | 43.2% | 79.4% | 85.3% | 67.6% | 49.4% | 50.4% | 62.5% | |
| 355.6% | -407.2% | 272.3% | 259.8% | 288.0% | 283.7% | 214.6% | 329.9% | 277.3% | 171.2% | 208.0% | 219.8% | 214.6% | |
| -258.1% | -238.1% | -186.2% | -166.8% | -192.6% | -191.8% | -123.6% | -234.3% | -184.6% | -78.6% | -126.0% | -132.0% | -125.8% | |
| 89.3% | 45.7% | 69.2% | 72.8% | 71.0% | 70.5% | 53.1% | 69.0% | 81.5% | 56.4% | 61.6% | 70.2% | 66.4% | |
| -330.5% | -249.3% | -257.3% | -208.6% | -237.6% | -183.6% | -166.9% | -294.0% | -249.4% | -29.5% | -164.6% | -86.1% | -123.5% | |
| -0.6% | 257.1% | 0.9% | 1.3% | 0.5% | -1.9% | 0.7% | 6.7% | -1.6% | -1.8% | – | – | – | |
| -329.9% | -506.4% | -258.2% | -209.9% | -238.1% | -181.7% | -167.6% | -300.7% | -249.4% | -27.8% | -164.6% | -86.1% | -123.0% | |
| -227.6% | -201.6% | -179.6% | -127.5% | -160.9% | -111.4% | -111.5% | -220.6% | -167.1% | 27.4% | -101.8% | -238.7% | -111.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.